Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 482 of 6351
-
New drug combo aims to boost chemo for tough bone cancer
Disease control Recruiting nowThe researchers are doing this study to find out whether adding gefitinib, trametinib, disulfiram, and sunitinib to standard chemotherapy is a more effective treatment approach for people with osteosarcoma than standard chemotherapy on its own. The researchers will also look at t…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Gene-Editing shot takes aim at inherited high cholesterol
Disease control Not yet recruitingThis study is an open-label, single ascending dose (SAD) study designed to evaluate the safety and tolerability of ART002g1 in patients with heterozygous familial hypercholesterolemia (HeFH) who require further reduction in low-density lipoprotein cholesterol (LDL-C). ART002g1 us…
Early phase 1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Glow-in-the-dark dye could light up lung tumors during surgery
Diagnosis Recruiting nowThe aim of this Phase 1b study is to investigate the safety and fluorescence signal of a single dose of Pemefolacianine for Injection, a novel fluorescence imaging agent developed by Nanjing Nuoyuan Medical Devices Co., Ltd (Nuoyuan Medical), administered by slow intravenous (IV)…
Phase 1 • Sponsor: Sunil Singhal • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
New hope for tough prostate cancer: drug combo trial launches
Disease control Recruiting nowThis study will evaluate the efficacy and safety of the combination of inavolisib plus enzalutamide compared with physician's choice of alternative androgen receptor pathway inhibitor (ARPi) or docetaxel in biomarker-selected participants with metastatic castrate-resistant prosta…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a 3-Week radiation course beat the standard for cervical cancer?
Disease control Recruiting nowThis phase II trial compares the effect of hypofractionated radiotherapy (HFRT) to conventional fractionated radiotherapy (CFRT) when given in combination with cisplatin and brachytherapy in patients with stage IB3, II, or III cervical cancer. Radiation therapy uses high energy x…
Phase 2 • Sponsor: Uganda Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for rare lung cancer: targeted drug trial launches
Disease control Recruiting nowThis study is an open-label, randomized, multicenter phase II/III clinical trial designed to evaluate the efficacy, safety, and tolerability of Andamertinib with or without platinum-based chemothsrapy versus platinum-based chemotherapy in previously untreated participants with lo…
Phase 2 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a flower extract heal parasitic skin ulcers? new trial seeks answers
Disease control Recruiting nowCutaneous leishmaniasis (CL) is a parasitic disease caused by more than 20 different species of the protozoan parasite Leishmania. CL usually begins with a papule at the site of the sandfly bite, which enlarges to form a nodule that progresses to an ulceration, or a scaly or wart…
Phase 3 • Sponsor: Universidad de Antioquia • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a gentle electric device ease chronic neck pain without drugs?
Symptom relief Recruiting nowShifting away from a medication-centered approach is a major public health priority, particularly in chronic pain management, where non-pharmacological therapies are recommended despite barriers such as limited evidence and low prescriber awareness. SCENAR (Self-Controlled Energ…
Sponsor: Hopital Foch • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Which steroid works best for severe pneumonia? major trial aims to find out
Disease control Recruiting nowThe goal of this cluster randomized controlled trial is to determine the optimal treatment for community aquired pneumonia (CAP). The study compares the effects and side effects of hydrocortisone and prednisolone in patients above 18 years old diagnosed with severe CAP. The main …
Phase 4 • Sponsor: Copenhagen Respiratory Research • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Smart MRI tailors cancer therapy for better outcomes
Disease control Not yet recruitingFUTURE-3 was a prospective, multicenter, single-arm phase II study designed to explore the efficacy and safety of MRI-guided individualized chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. The primary endpoint was one-year progression-free survival rate.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Swab test could spot hidden uterine cancer early
Diagnosis Recruiting nowThis is a multicenter, prospective, specimen collection study for development and evaluation of tests used to detect endometrial cancer, other cancers, or their causes.
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
New hope for lung cancer: smart combo targets hidden risk after immunotherapy
Disease control Recruiting nowThe CR1STAL-Adaptive study is a randomized, open-label, phase II multicenter interventional trial designed to evaluate the safety and efficacy of Ivonescimab (PD-1/VEGF bispecific antibody) combined with docetaxel versus standard treatment in patients with advanced NSCLC who have…
Phase 2 • Sponsor: Second Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a drug cocktail save Insulin-Making cells in newly diagnosed kids?
Disease control Recruiting nowThis multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in persons aged 9 to \<21 with recent-onset stage 3 T1D.
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill aims to calm lupus skin flares in major trial
Disease control Recruiting nowThe purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of lupus erythematosus with or without systemic disease. Study details include: Study Duration: Up to 35 …
Phase 3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for lung cancer patients: experimental drug SYS6010 faces off against chemotherapy
Disease control Not yet recruitingThis is a randomized, open-label, multicenter Phase III clinical trial, designed to evaluate the efficacy and safety of SYS6010 versus docetaxel in participants with Locally Advanced or Metastatic EGFR Wild-type Non-squamous Non-small Cell Lung Cancer who Have Failed Standard The…
Phase 3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
No X-Rays, no dye: new heart valve procedure could protect kidneys
Disease control Not yet recruitingTranscatheter aortic valve replacement (TAVR) is an established therapy for severe aortic valve disease, yet conventional workflows rely on fluoroscopy and iodinated contrast, exposing patients and operators to ionizing radiation and posing challenges for individuals with chronic…
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New inhaled therapy aims to slow lung scarring in IPF
Disease control Recruiting nowThis study will evaluate the impact Nintedanib Solution for Inhalation (AP02) has on lung function and key measures of fibrosis in adult patients with idiopathic pulmonary fibrosis (IPF) as well as assess its safety and tolerability. Adults 40 years of age or older with IPF who …
Phase 2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
AI eye doctor: new model diagnoses diseases from photos
Diagnosis Recruiting nowAccurate and comprehensive interpretation of anterior segment diseases from slit-lamp and smartphone photographs remains a clinical challenge due to the limited specificity and structure of existing Artificial Intelligence tools. The purpose of this international, multicenter cli…
Sponsor: Guangdong Provincial People's Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New hope for tough lymphoma: glofitamab under Real-World microscope
Disease control Not yet recruitingThis is a prospective, observational, non-interventional real-world study that will not alter participants' routine clinical care. Approximately 20 eligible patients with diffuse large B-cell lymphoma (DLBCL) will be enrolled. Treatment decisions will be made by the treating phys…
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Not yet recruitingThis is a prospective, single-center, single-arm clinical study. It aims to evaluate the efficacy and safety of a new combination therapy as a first-line treatment for patients with advanced intrahepatic cholangiocarcinoma (ICC) who cannot be treated with surgery. The combined th…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC